PARSIPPANY, N.J., Aug. 26, 2025 (GLOBE NEWSWIRE) — Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that management will participate in the following investor events:
2025 Wells Fargo Healthcare Conference
- Management will host a fireside session on Thursday, September 4, 2025, at 3:00 p.m. EDT and one-on-one investor meetings throughout the day at the Encore Boston Harbor Hotel, Boston.
2025 Morgan Stanley 23rd Annual Global Healthcare Conference
- Management will host one-on-one investor meetings on Tuesday, September 9, 2025, at Sheraton New York Times Square, New York City.
About embecta
embecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, helping to improve lives through innovative solutions, partnerships, and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram.
Contacts:
| Media | Investors |
| Christian Glazar | Pravesh Khandelwal |
| Sr. Director, Corporate Communications | VP, Head of Investor Relations |
| 908-821-6922 | 551-264-6547 |
| Contact Media Relations | Contact IR |
Please visit:
Our Sponsor